• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2004 - 2019年伊朗南部乳腺癌和妇科癌症导致的死亡率及寿命损失年数:一项基于人群的研究

Mortality Rate and Years of Life Lost Due to Breast and Gynecologic Cancers in Southern Iran 2004-2019: A Population-Based Study.

作者信息

Azarbakhsh Habibollah, Heiran Alireza, Askarinejad Amir, Hassanzadeh Jafar, Janfada Maryam, Mirahmadizadeh Alireza

机构信息

Department of Epidemiology, Faculty of Health, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.

Non-Communicable Diseases Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.

出版信息

Iran J Public Health. 2024 Aug;53(8):1890-1897. doi: 10.18502/ijph.v53i8.16295.

DOI:10.18502/ijph.v53i8.16295
PMID:39415873
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11475166/
Abstract

BACKGROUND

There is an increase in the incidence of breast and gynecologic cancers in Iran during the last three decades. Literature is inadequate about the Years of Life Lost (YLL) attributed to these cancers in Iran.

METHODS

Mortality data due to these cancers amongst females aged >20 yr from 2004 to 2019 was acquired from "Electronic Death Registry System", Fars Province, Iran. Using local health centers' databases and national census reports from 1996 to 2016, the age-standardized incidence rate (ASR) per 100,000 people were estimated. YLLs were calculated using the WHO's 2015 "YLL template".

RESULTS

During 2004-2019, 1886 and 829 deaths occurred due to breast and gynecologic cancers, respectively. The ASR due to breast and gynecologic cancers showed a significant increasing trend (<0.001 for each). The total YLL due to breast, cervical/uterine/vaginal/vulvar, and ovary cancers' deaths in the 16-year period were 33,077, 7,172 and 6,584 yr, respectively. The highest YLLs were observed in 50-59-year-old females, followed by 40-49- and 60-69-year-old females. The 16- year trend of YLL rate due to premature mortality in breast cancer, ovary cancer and cervix cancer was increasing: annual percent change (APC) was 7.6% (95% CI: 5.5-9.7, <0.001), 19.0% (95% CI: 12.2-26.1, <0.001) and 9.2% (95% CI: -9.2 to 31.3, >0.05, respectively.

CONCLUSION

Mortality rate and YLLs due to breast and gynecologic cancers have been increased in southern Iran during the last twenty years. Early detection programs and allocating treatments at early stages should be prioritized.

摘要

背景

在过去三十年中,伊朗乳腺癌和妇科癌症的发病率有所上升。关于伊朗这些癌症导致的寿命损失年数(YLL)的文献资料不足。

方法

从伊朗法尔斯省的“电子死亡登记系统”获取了2004年至2019年20岁以上女性因这些癌症导致的死亡数据。利用当地卫生中心的数据库和1996年至2016年的全国人口普查报告,估算了每10万人的年龄标准化发病率(ASR)。使用世界卫生组织2015年的“YLL模板”计算YLL。

结果

2004年至2019年期间,分别有1886例和829例死亡是由乳腺癌和妇科癌症导致的。乳腺癌和妇科癌症的ASR呈显著上升趋势(每种趋势的P值均<0.001)。在这16年期间,乳腺癌、宫颈癌/子宫癌/阴道癌/外阴癌以及卵巢癌死亡导致的YLL总数分别为33077年、7172年和6584年。YLL最高的是50至59岁的女性,其次是40至49岁和60至69岁的女性。乳腺癌、卵巢癌和宫颈癌过早死亡导致的YLL率在16年期间呈上升趋势:年变化百分比(APC)分别为7.6%(95%CI:5.5 - 9.7,P<0.001)、19.0%(95%CI:12.2 - 26.1,P<0.001)和9.2%(95%CI:-9.2至31.3,P>0.05)。

结论

在过去二十年中,伊朗南部乳腺癌和妇科癌症的死亡率及YLL有所增加。应优先开展早期检测项目并在早期阶段分配治疗资源。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/13f7/11475166/45ad589b7b7d/IJPH-53-1890-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/13f7/11475166/92a5bc605c7c/IJPH-53-1890-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/13f7/11475166/45ad589b7b7d/IJPH-53-1890-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/13f7/11475166/92a5bc605c7c/IJPH-53-1890-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/13f7/11475166/45ad589b7b7d/IJPH-53-1890-g002.jpg

相似文献

1
Mortality Rate and Years of Life Lost Due to Breast and Gynecologic Cancers in Southern Iran 2004-2019: A Population-Based Study.2004 - 2019年伊朗南部乳腺癌和妇科癌症导致的死亡率及寿命损失年数:一项基于人群的研究
Iran J Public Health. 2024 Aug;53(8):1890-1897. doi: 10.18502/ijph.v53i8.16295.
2
Trend Analysis of Leukemia Mortality and Years of Life Lost (YLL) from 2004 to 2019 in the Fars Province, Iran.伊朗法尔斯省 2004 年至 2019 年白血病死亡率和生命损失年数(YLL)的趋势分析。
Arch Iran Med. 2023 Oct 1;26(10):547-553. doi: 10.34172/aim.2023.80.
3
Trend Analysis of Lung Cancer Mortality and Years of Life Lost (YLL) in South of Iran, 2004-2019.2004 - 2019年伊朗南部肺癌死亡率及寿命损失年数(YLL)的趋势分析
Iran J Public Health. 2024 Jan;53(1):238-245. doi: 10.18502/ijph.v53i1.14700.
4
Trend Analysis of Suicide Mortality and Years of Life Lost from 2016 to 2021 in Southern Iran.2016年至2021年伊朗南部自杀死亡率及生命损失年数的趋势分析
Iran J Public Health. 2024 May;53(5):1128-1136. doi: 10.18502/ijph.v53i5.15594.
5
The Burden of Premature Mortality in Southern Iran during 2004-2019 Using Standard Expected Years of Life Lost: A Population-Based Study.2004年至2019年伊朗南部过早死亡负担:基于标准预期寿命损失年数的人群研究
Iran J Public Health. 2023 Oct;52(10):2196-2206. doi: 10.18502/ijph.v52i10.13858.
6
Trend analysis of asthma mortality and years of life lost from 2004 to 2019 in Southern Iran.2004年至2019年伊朗南部哮喘死亡率及寿命损失年数的趋势分析。
Lung India. 2023 Sep-Oct;40(5):412-417. doi: 10.4103/lungindia.lungindia_530_22.
7
The Trend of Years of Life Lost due to Gastrointestinal Cancers in Fars (Iran) 2004-2019.2004 - 2019年伊朗法尔斯省因胃肠道癌症导致的寿命损失趋势
Iran J Public Health. 2024 Mar;53(3):671-679. doi: 10.18502/ijph.v53i3.15149.
8
Trend of Mortality Rate and Years of Life Lost due to Cerebrovascular Diseases in Fars Province, Iran (2004-2019).伊朗法尔斯省脑血管疾病死亡率和寿命损失年趋势(2004-2019 年)。
Arch Iran Med. 2023 Apr 1;26(4):198-204. doi: 10.34172/aim.2023.30.
9
Trend Analysis of Unintentional Fall Mortality and Years of Life Lost in the Fars Province of Iran, 2004-2019.2004 - 2019年伊朗法尔斯省意外跌倒死亡率及生命损失年数的趋势分析
Iran J Public Health. 2024 Jun;53(6):1427-1436.
10
Years of Life Lost due to Suicide in Southern Iran 2011-18: A Population-Based Study.2011-2018 年伊朗南部因自杀导致的寿命损失年数:一项基于人群的研究。
Arch Iran Med. 2022 Jan 1;25(1):12-16. doi: 10.34172/aim.2022.03.

本文引用的文献

1
Economic Burden of Gynecological Cancers in Iran.伊朗妇科癌症的经济负担。
Value Health Reg Issues. 2022 Mar;28:1-6. doi: 10.1016/j.vhri.2021.02.005. Epub 2021 Nov 15.
2
Burden of Cervical Cancer in the Eastern Mediterranean Region During the Years 2000 and 2017: Retrospective Data Analysis of the Global Burden of Disease Study.2000 年至 2017 年期间东地中海区域宫颈癌负担:全球疾病负担研究的回顾性数据分析。
JMIR Public Health Surveill. 2021 May 12;7(5):e22160. doi: 10.2196/22160.
3
National and Subnational Incidence, Mortality, and Years of Life Lost Due to Breast Cancer in Iran: Trends and Age-Period-Cohort Analysis Since 1990.
伊朗乳腺癌导致的全国及各地区发病率、死亡率和寿命损失年数:1990年以来的趋势及年龄-时期-队列分析
Front Oncol. 2021 Mar 25;11:561376. doi: 10.3389/fonc.2021.561376. eCollection 2021.
4
National and Subnational Trends of Incidence and Mortality of Female Genital Cancers in Iran; 1990-2016.伊朗女性生殖系统癌症发病率和死亡率的国家和次国家趋势;1990-2016 年。
Arch Iran Med. 2020 Jul 1;23(7):434-444. doi: 10.34172/aim.2020.40.
5
Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis.2018 年宫颈癌发病率和死亡率的估计:全球分析。
Lancet Glob Health. 2020 Feb;8(2):e191-e203. doi: 10.1016/S2214-109X(19)30482-6. Epub 2019 Dec 4.
6
Ovarian Cancer: An Integrated Review.卵巢癌:综合述评。
Semin Oncol Nurs. 2019 Apr;35(2):151-156. doi: 10.1016/j.soncn.2019.02.001. Epub 2019 Mar 11.
7
Breast Cancer Epidemiology, Prevention, and Screening.乳腺癌流行病学、预防和筛查。
Prog Mol Biol Transl Sci. 2017;151:1-32. doi: 10.1016/bs.pmbts.2017.07.002. Epub 2017 Oct 10.
8
Survival Rate of Breast Cancer in Iran: A Meta-Analysis.伊朗乳腺癌的生存率:一项荟萃分析。
Asian Pac J Cancer Prev. 2016 Oct 1;17(10):4615-4621. doi: 10.22034/apjcp.2016.17.10.4615.
9
Fitting Cure Rate Model to Breast Cancer Data of Cancer Research Center.将治愈率模型应用于癌症研究中心的乳腺癌数据。
Asian Pac J Cancer Prev. 2015;16(17):7923-7. doi: 10.7314/apjcp.2015.16.17.7923.
10
Burden of Breast Cancer in Iranian Women is Increasing.伊朗女性乳腺癌负担正在加重。
Asian Pac J Cancer Prev. 2015;16(12):5049-52. doi: 10.7314/apjcp.2015.16.12.5049.